COMPARATIVE ADHERENCE TRAJECTORIES OF ORAL FINGOLIMOD AND INJECTABLE DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS

被引：0
|
作者：
Earla, J. R. [1 ]
Hutton, G. J. [2 ]
Thornton, J. D. [1 ]
Chen, H. [1 ]
Johnson, M. L. [1 ]
Aparasu, R. [1 ]
机构：
[1] Univ Houston, Houston, TX USA
[2] Baylor Coll Med, Med Ctr, McNair Campus, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND104
引用
收藏
页码：S279 / S279
页数：1
相关论文
共 50 条
  • [31] Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review
    Yoon, Ee Ling
    Cheong, Wing Loong
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 104 - 108
  • [32] Injectable Disease-Modifying Therapy for Relapsing-Remitting Multiple Sclerosis: A Review of Adherence Data
    Caon, Christina
    Saunders, Carol
    Smrtka, Jennifer
    Baxter, Nancy
    Shoemaker, Jennifer
    JOURNAL OF NEUROSCIENCE NURSING, 2010, 42 (05) : S5 - S9
  • [33] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [34] Longitudinal Adherence Trajectories of Patients with Multiple Sclerosis Initiating Once- or Twice-Daily Oral Disease-Modifying Therapies
    Cisternas, M. G.
    Halpern, R.
    Leszko, M.
    Andrade, K.
    Phillips, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 51 - 52
  • [35] ADHERENCE TO GLATIRAMER ACETATE 40 MG VERSUS ORAL DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Halpern, R.
    Wolbeck, R.
    Blauer-Peterson, C.
    Wu, Y.
    Gandhi, S. K.
    VALUE IN HEALTH, 2015, 18 (07) : A766 - A766
  • [36] Multiple Sclerosis: Overview of Disease-Modifying Agents
    Finkelsztejn, Alessandro
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 65 - 72
  • [37] Persistence with multiple sclerosis disease-modifying therapies is highest when switching to fingolimod compared with other oral and injectable therapies: a retrospective US claims database analysis
    Korn, Jonathan
    Medin, Jennie
    Fang, Juanzhi
    Putzki, Norman
    NEUROLOGY, 2017, 88
  • [38] Oral Fingolimod (Gilenya) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1353): : 98 - 102
  • [39] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [40] Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy
    Thannhauser, Jennifer E.
    Mah, Jean K.
    Metz, Luanne M.
    PEDIATRIC NEUROLOGY, 2009, 41 (02) : 119 - 123
12345